The medical journey we are changing: 4 phases in allergology practice
A careful medical history is the basis for successful allergy therapy, but in just 5 minutes (Germany EBM) this is an enormous challenge for both - doctor and patient.
.jpg)
Dramatic insufficient supply:
-
Today, the entire allergology journey still takes place in the doctor's office.
-
However, there are too many allergy sufferers and too few allergists.
-
50% of allergy sufferers are underdiagnosed.
-
Insufficient supply: long waiting times for an appointment, too imprecise diagnostics, too little time for the patient
The untreated allergy sufferer is the asthmatic of tomorrow
What is the innovation that improves the care of allergy sufferers?
allergoSMART uses AI to implement all phases of the allergology journey in one system
allergoSMART AI
the world's first digital AI system to turn medical data into personalized allergy medicine
allergoSMART Anamnesis
Speech-processing
AI tool
-
Patient makes an interview with the Allergo AI tool
-
Digital tool replaces paper sheets
-
The medical history can be taken at any time and in any place - living room instead of waiting room
-
The medical history is not a static process, it is adaptable, accurate and up-to-date
-
Physician receives a structured and up-to-date medical history with Ai-based medical analysis for further diagnostics
allergoSMART Pricktest
Image-processing
AI tool
-
Practice employee only photographs the result of the prick test
-
The allergoSMART AI recognizes all relevant markers through digital AI calibration
-
The circumference, diameter, height and area of the allergic reaction are precisely determined and displayed in 3D
-
Allergo AI automatically links all data from the medical history and the prick test for optimal diagnostic results
-
On request, Allergo AI will provide the doctor a therapy recommendation
allergoSMART
Therapy recommandation
Ai-supported therapy proposal
-
Results of medical history and prick test are consolidated
-
allergoSMART AI analyzes all existing data and the latest findings from medicine and allergy research
-
Based on the evaluation of all data and the results of the diagnostics, Allergo AI creates a therapy suggestion
-
The doctor checks the suggestion and confirms or adjusts the therapy
-
At the end, the doctor can conduct the therapy discussion with the patient online
allergoSMART
Allergy Therapy
AI supported personalized allergy medicine
-
Allergo 3 D printer closes the therapy gap
-
1000 therapy allergens are available, from which a correspondingly large number of mixtures are possible
-
The allergy sufferer receives exactly the allergy preparation that they individually need
-
allergoSMART monitors and adjusts the medication
The smart idea behind allergoSMART
AllergoSMART is more than a system; it is a movement towards a future where allergies no longer dictate lives. We invite everyone to be part of this transformative journey. Whether you are a healthcare professional, a researcher or someone who is passionate about advancing medical care, AllergoSMART offers the opportunity to be at the forefront of a medical revolution. Together we can build an Allergo World where everyone can breathe easier, live fuller and reach their full potential, unhindered by allergies. Welcome to the future of allergy care.
Welcome to allergoSMART
Mite allergy: the most common indoor allergy worldwide. A global health issue.
High market relevance
allergoSMART for doctors
Flexible billing model
-
Patient-oriented and doctor-specific license model
-
Various service modules
-
Doctors choose which service they want to use and activate
Comprehensive medical plan recommended.
When embedded in an overall concept for the reduction of house dust mite allergens, these individual measures, such as the use of encasings, have a significantly better effect.
The guideline for allergy prevention revised by the German allergological professional associations in 2022 also recommends measures to reduce mite exposure as part of secondary and tertiary prevention.
Ludger Klimek, Randolf Brehler, Karl-Christian Bergmann, Ingrid Casper, Felix Klimek, Jan Hagemann, Marie-Luise Polk, Mandy Cuevas in HNO Nachrichten 1/2024
allergo SMART : the world's first AI-based complete solution for personalized mite allergen avoidance.
The intelligent solution for allergies and health AI
Available in any language,
even Klingon.
This is how allergoSMART
works
01
Take a photo of your living spaces
Simply upload photos of your relevant living areas. These images form the basis for a precise, AI-supported analysis of your environment.
02
Start the image analysis now
Our AI recognizes potential improvements to alleviate your allergy. It analyzes step by step and also gives you the medical background.
03
Better results with an uploaded allergy test
04
The customized AI living space plan is created by SASHA
Sasha can even recognize your allergy test and prick test and evaluate them based on your living space. Then SASHA can tailor its adjustments even better to your specific needs.
Now you will receive a customized plan of how you and your family can change small things. You will be surprised at the effect this can have. Together with the Allergo Encasing, you and your family are now optimally set up.
Integrated networked care
Submitting prescriptions
Aids Prescription applications
Receive approval
Create accounting
supply chain
fully transparent
_edited.png)
About us and the Allergo AI Solution Group
Allergo started developing and producing mattress and bed and pillow encasings for dust mite allergy and asthma sufferers more than 30 years ago. With our allergy encasings, we want to create a healthy sleeping environment in a safe and easy way that helps dust mite allergy and asthma sufferers gently relieve their symptoms and achieve a better quality of life.
Our brand ALLERGOCOVER is the oldest and most experienced encasing brand in Europe, with a history stretching back almost 40 years. The father of our founder was instrumental in the development of ALLERGOCOVER as a textile engineer. The history of our company has always been closely linked to ALLERGOCOVER.
But looking to the future has always been one of our driving forces. With the introduction of the AI-supported individual home check and the digital AI allergy assistant SASHA, Allergo continues to lead the way in the development of allergen avoidance.
By also starting to build up the structure in the USA (Austin, Texas) and an efficient and modern company form that is geared towards international expansion, Allergo can bring its digital and innovative AI solutions to use worldwide.
Just as the father of our founder did back then with the packaging of ALLERGOCOVER. That is what tradition means to us.
